drugset / Trial / NCT00294502

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

NCT00294502 ↗

Phase 4 Completed 120 enrolled Henry Ford Health System
RandomizedSingle-groupOpen-labelPrevention

Summary

To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.

Timeline

Start
2003-09
Primary completion
—
Completion
2004-05

Outcome

Met primary endpoint

paper Infection rates per 100 catheter-days were 0.03 in the gentamicin group versus 0.42 in the heparin group (P = 0.003). PMID 12138146 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject EDTA Unknown — Other
Subject Gentamicin Small molecule — Other
Subject Minocycline Small molecule — Other
Subject citrate Unknown — Other